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Abstract
Background: The vertebrate body plan is generated during gastrulation with the formation of the
three germ layers. Members of the Nodal-related subclass of the TGF-β superfamily induce and
pattern the mesoderm and endoderm in all vertebrates. In zebrafish, two nodal-related genes, called
squint and cyclops, are required in a dosage-dependent manner for the formation of all derivatives
of the mesoderm and endoderm. These genes are expressed dynamically during the blastula stages
and may have different roles at different times. This question has been difficult to address because
conditions that alter the timing of nodal-related gene expression also change Nodal levels. We
utilized a pharmacological approach to conditionally inactivate the ALK 4, 5 and 7 receptors during
the blastula stages without disturbing earlier signaling activity. This permitted us to directly examine
when Nodal signals specify cell types independently of dosage effects.
Results: We show that two drugs, SB-431542 and SB-505124, completely block the response to
Nodal signals when added to embryos after the mid-blastula transition. By blocking Nodal receptor
activity at later stages, we demonstrate that Nodal signaling is required from the mid-to-late
blastula period to specify sequentially, the somites, notochord, blood, Kupffer's vesicle, hatching
gland, heart, and endoderm. Blocking Nodal signaling at late times prevents specification of cell
types derived from the embryo margin, but not those from more animal regions. This suggests a
linkage between cell fate and length of exposure to Nodal signals. Confirming this, cells exposed to
a uniform Nodal dose adopt progressively more marginal fates with increasing lengths of exposure.
Finally, cell fate specification is delayed in squint mutants and accelerated when Nodal levels are
elevated.
Conclusion: We conclude that (1) Nodal signals are most active during the mid-to-late blastula
stages, when nodal-related gene expression and the movement of responding cells are at their most
dynamic; (2) Nodal signals specify cell fates along the animal-vegetal axis in a time-dependent
manner; (3) cells respond to the total cumulative dose of Nodal signals to which they are exposed,
as a function of distance from the source and duration of exposure.
Background
During vertebrate development, cells become irreversibly
committed to particular fates after a series of inductive
events. The first step of this process is completed during
gastrulation, when cells are allocated to the three germ
layers. Fate maps of vertebrate embryos show considera-
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ble organization before gastrulation, since different meso-
dermal and endodermal structures are derived from
distinct positions along the major body axes [1-3]. In
zebrafish late blastula stage embryos, for example, endo-
derm progenitors are restricted to the four rows of cells
closest to the yolk, known as the margin, while mesoderm
precursors extend further towards the animal pole [4,5].
The germ layers are also patterned along the dorsoventral
axis, such that the notochord is derived from dorsal mes-
oderm, the heart comes from lateral mesoderm and blood
comes from ventral mesoderm [6,7]. TGF-β signals of the
Nodal-related subclass are required to induce and pattern
the germ layers in vertebrates [8]. Nodal signaling is medi-
ated by a receptor complex containing the TGF-β Type I
receptor, ALK4, the Type II receptor, ActR-IIB, and the
Cripto/One- Eyed-pinhead (Oep) co-receptor [9,10]. The
Nodal receptors can also be activated by other TGF-β lig-
ands, including Activin and Vg1 [9,11]. For this reason,
the Nodalrelated proteins, Activin and Vg1 are collectively
termed Activin-like signals.
The requirement for Nodal-related proteins to induce
mesoderm and endoderm is conserved throughout the
vertebrate lineage [8]. There are three nodal-related genes
in zebrafish, but only two, squint (sqt/ndr1) and cyclops
(cyc/ndr2), have overlapping roles in mesendoderm for-
mation [12]. The third nodal-related gene, southpaw (spaw/
ndr3), is only expressed after gastrulation and is involved
in establishing the left-right body axis [13]. In cyc single
mutants, defects in mesendoderm are first detected at
mid-gastrulation and the embryos lack floorplate and
ventral diencephalon at later stages [14-16]. sqt  single
mutants have severe deficits in dorsal mesodermal deriva-
tives at early stages, but the embryos recover and many
survive to adulthood [17,18]. This recovery depends on
cyc function, since sqt; cyc double mutants lack all deriva-
tives of the mesoderm and endoderm in the head and
trunk, including the skeletal muscle, heart, pronephros,
blood and gut [19].
Both gain-and loss-of-function studies indicate that
Activin-like signals act in a concentration-dependent
manner to specify cell fates [20-23]. In explants, high
doses induce marginal cell types, such as prechordal plate
and endoderm, whereas lower doses induce notochord
and muscle [24]. Conversely, endoderm and prechordal
plate are more sensitive to reductions in Nodal levels than
are notochord and muscle [17,23]. Zebrafish Sqt behaves
like a morphogen, acting directly on cells at a distance to
specify fates in a concentration dependent manner
[25,26]. These results and other data have led to the sug-
gestion that cells adopt fates depending on their position
within a gradient of Nodal-related protein [27].
A spatial gradient model of Nodal signaling, however,
does not account for two key observations. For example,
in the animal region of the mesoderm territory in pregas-
trula stage embryos, somite precursors are intermingled
with neurectoderm progenitors, which are specified in the
absence of Nodal function [5,17]. Near the margin, by
contrast, somite precursors are intermingled with endo-
derm precursors, which require high levels of Nodal
[4,17]. This raises the question of how adjacent cells could
be exposed to different Nodal doses. Secondly, Cyc can
fully compensate for loss of the Sqt morphogen despite
the fact that it only acts over a short range [17,25,28]. This
indicates that the long-range action of Nodal signals is not
necessary for correct induction and patterning of the mes-
oderm and endoderm.
Experiments suggest that the role of Nodal signaling is
quite dynamic, but it has been difficult to determine what
are the functions of Nodal signals at different times. The
expression pattern of nodal-related genes changes rapidly
during the blastula stages in frogs, fish and mice
[21,24,29,30]. Efforts to determine when Nodal signals
specify distinct mesodermal and endodermal cell types
have been hampered by the fact that conditions which
alter the timing of Nodal signaling also change the levels
of nodal related gene expression. For example, levels of
Nodal decrease in zygotic oep mutants as maternally sup-
plied Oep mRNA and protein decay and eventually disap-
pear [31,32]. Similarly, cyc expression is both reduced and
delayed in sqt mutants [17]. Thus, it has not been possible
to determine whether the fate changes observed in these
mutants are due to altered timing of Nodal signaling or to
the reduction in Nodal activity.
Experiments in frogs and fish have suggested two mecha-
nisms by which Nodal signals may act to specify different
tissues at different times. When Xenopus animal cap cells
are exposed to Activin-soaked beads for different lengths
of time, the responding cells exhibit a stepwise progres-
sion of cell fate specification as a concentration gradient
of Activin is established within the explant [33]. These
results suggested that cells constantly monitor ligand lev-
els and "ratchet-up" their response when the concentra-
tion exceeds certain threshold levels. In this view, cell fates
are determined by the absolute number of receptors occu-
pied by the ligand rather than by how long cells are
exposed to the ligand [34,35]. By contrast, experiments in
zebrafish with a conditional allele of cyc determined that
cells need to be exposed to Nodal signals during a two-
hour window in order to become floorplate [36]. This
raised the possibility that cells respond differently to
Nodal signals depending on when they are exposed. In
this view, cells have intrinsically defined periods during
which they are able to adopt particular fates if exposed to
the proper Nodal dose.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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We have utilized a pharmacological approach to deter-
mine when Nodal signals specify the different mesoder-
mal and endodermal cell types in the zebrafish. For the
first time, we have been able to block the activity of Nodal
receptors during discrete blastula stages by treatment with
the small molecules SB-431542 or SB-505124 and with-
out disrupting signaling at earlier stages or altering endog-
enous Nodal levels [37,38]. We find that Nodal signals
specify most mesodermal and endodermal cell types
between the mid-blastula (3 h) and late blastula (5 h)
stages. By examining embryos with increased or decreased
levels of Sqt and Cyc signals, we show that the Nodal dose
controls the timing of cell fate specification. This rules out
the idea that cells adopt different mesoderm and endo-
derm fates depending on when they are exposed to Nodal
signals. We also show that embryonic cells respond to a
uniform, high dose by adopting progressively more mar-
ginal fates with longer exposures to Nodal signals. This
time-dependent transformation of cell fates is inconsist-
ent with some aspects of the ratchet model. We conclude
that cells respond to the total cumulative dose of Nodal
signals to which they are exposed, as a function of dis-
tance from the source and duration of exposure.
Results
Drug treatment at MBT prevents the response to zygotic 
Nodal signals in embryos
To determine when Sqt and Cyc signals induce and pat-
tern the germ layers, we developed a drug-based strategy
that permits us to block endogenous Nodal signals at dif-
ferent stages after the mid-blastula transition (MBT). SB-
431542 binds competitively to the ATP binding sites of
the ALK 4, 5 and 7 receptors, preventing their kinase activ-
ity [39]. This drug has been used previously on zebrafish
embryos during the cleavage stages, but did not com-
pletely block Nodal signals when added after MBT
[40,41]. Therefore, we developed a protocol to use SB-
431542 to block zygotic Nodal signals in whole embryos
between MBT (2.75 h) and the onset of gastrulation (6 h)
(see Methods). Control embryos had a normal morphol-
ogy at 24 h, indicating that our manipulations did not
affect early embryogenesis (Fig. 1A–C). By contrast,
embryos treated with 800 μM SB-431542 display severe
cyclopia and lack all derivatives mesoderm and endoderm
in the head and trunk, including the somites, notochord,
blood, heart and Kupffer's vesicle (Fig. 1D–F). These
defects strongly resemble those previously described for
sqt; cyc double mutants [19]. Like sqt; cyc double mutants,
SB-431542 treated embryos lack axial expression of the
pan-mesendodermal marker no-tail  (ntl) and the noto-
chord marker floating head (flh) (Fig. 1J, L, O, Q). Interest-
ingly,  flh  expression in the neurectoderm is greatly
expanded in drug treated embryos, suggesting an
expanded epiphysis (Fig. 1Q) [42]. Drug treated embryos
also lack MyoD expression at 14 h (Fig. 1K, P). Since tail
somites do not form until later stages, this indicates that
trunk somites are missing [43]. The prechordal plate and
pronephros are also missing in these embryos, as indi-
cated by the lack of goosecoid (gsc) and pax2.1 expression,
respectively (Fig. 1R, M; Fig. 3C, D). Drug treated embryos
also lack expression of sonic hedgehog b (shhb), indicating
the absence of floorplate (Fig. 1N, S). Because high con-
centrations of the drug were necessary to produce these
defects, we next asked if we could achieve similar results
with SB-505124, a more potent and bioactive inhibitor of
the ALK 4/5/7 receptors than SB-431542 [38]. 30–50 μM
of SB-505124 is sufficient to phenocopy sqt; cyc mutants
when added at MBT (Fig. 1G–I). The ability of both drugs
to phenocopy sqt; cyc mutants when added to 2.75 h
embryos indicates that they reduce ALK 4/5/7 receptor
activity to levels as low as that in zygotic mutants null for
nodal-related gene function. Subsequent experiments were
performed with SB-431542 and confirmed with SB-
505124 as indicated.
To determine how quickly we could observe the effects of
the drug, we examined the expression of the Nodal target
gene lefty1 in a time course of embryos treated with SB-
431542 at dome stage (4.3hpf) [44]. We found that tran-
scription of Nodal target genes is normal 15 minutes after
treatment (Fig. 2A, D; N = 11), but is severely reduced after
30 minutes (Fig. 2B, E; N = 24). No transcripts are
detected 45 minutes after treatment (Fig. 2C, F; N = 21).
Therefore, transcription of Nodal-dependent genes is rap-
idly blocked after drug treatment and the decrease in
mRNA levels is apparent within 15–30 minutes.
We next asked if SB-431542 could prevent the response to
a mutated and constitutively-activated receptor that is
active even in the absence of ligand, such as TARAM-D
[39].  TARAM-D  acts in a cell-autonomous manner to
induce expression of Nodal target genes, resulting in dor-
salized embryos and expanded gsc expression (Fig. 3E, G;
N = 30) [28,45]. In most cases, SB-431542 completely
suppresses the response to TARAM-D, consistent with its
proposed mode of action (data not shown). In the course
of our experiment, however, occasional embryos received
higher doses of the activated receptor and displayed a
milder phenotype than their siblings. These embryos have
cyclopia and reduced or absent mesodermal tissues,
including trunk somites and notochord (Fig. 3F). gsc
expression is dramatically reduced in these embryos (Fig.
3G, H; N = 20). Thus, high levels of activated receptor can
rescue the defects caused by the drug. This demonstrates
the specificity of the drug, since the activated Nodal recep-
tor would not rescue defects caused by blocking receptors
for other signaling pathways. SB-431542 also blocks the
response to ubiquitously expressed Sqt (Fig. 3I–L). Thus,
the drug is able to effectively penetrate and act within the
entire embryo. In these experiments, we injected embryosBMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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Treatment with 800 μM SB-431542 or 50 μM SB-505124 at MBT prevents formation of mesoderm and endoderm Figure 1
Treatment with 800 μM SB-431542 or 50 μM SB-505124 at MBT prevents formation of mesoderm and endo-
derm. (A-F) Images of live embryos at 24hpf treated at 2.75 h with DMSO (A-C), SB-431542 (D-F; J-S), or SB-505124 (G-I). 
Embryos treated with SB-431542 (D-F) or SB-505124 (G-I) lack derivatives of the mesoderm and endoderm in the head and 
trunk, display severe cyclopia and lack Kupffer's vesicle. (J-P) Images of embryos treated with DMSO (J-N) or SB-431542 at 
MBT (O-S) and processed to reveal expression of markers for derivatives of dorsal mesoderm (ntl: J, O; flh: L, Q), paraxial 
mesoderm (myoD: K, P), intermediate mesoderm (pax2.1: M, R), and ventral neurectoderm (shhb: N, S). Dorsal views of 
embryos fixed at 10 h (J, L, N, P, Q, S)or 14 h (K, M, P, R). Arrowhead in (C) is the Kupffer's vesicle.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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with sqt or TARAM-D mRNA at the 1–4 cell stage (1 h) and
treated with the drug at 2.75 h. Therefore, SB-431542 can
block the response to receptors already present during the
cleavage stages. Because the drug is effective at blocking
Nodal signaling when applied as late as 2.75 h, this sug-
gests that maternally supplied Activin-like ligands nor-
mally act after MBT, if at all, to effect specification of cell
fates.
Nodal signals specify mesodermal tissues at different times 
within a three-hour period
To determine when Nodal signals specify the various mes-
odermal cell types, we treated embryos with SB-431542 at
successively later time points during the blastula stages
and scored mesodermal tissues by morphology and
marker gene expression. No mesodermal derivatives are
present in the head and trunk when embryos are treated
with the drug at MBT (Fig. 1). By contrast, embryos treated
with SB-431542 at 6 h, when cyc  expression predomi-
nates, produced a phenocopy of cyc single mutants (Fig.
4E1-8). These embryos display severe cyclopia, have a
ventrally curved body axis and lack the floorplate, as indi-
cated by the absence of shhb expression (Fig. 4E1, 2, 8)
[14,36]. Thus, SB-431542 treatment in early gastrulation
reduces ALK 4/5/7 activity to levels at or below those in cyc
null mutants. A number of mesodermal cell types are
present in embryos treated at this stage, including
somites, notochord, heart, blood, pronephros, and hatch-
ing gland (Fig. 4E3-7; Fig. 5). This defines a three-hour
time window beginning at MBT during which Nodal sig-
nals are required to specify mesodermal tissues. Embryos
treated after mid-gastrulation contain floorplate as
revealed by shhb expression (data not shown), confirming
earlier temperature shift experiments using a temperature
sensitive allele of cyc [36].
We next treated embryos with SB-431542 at different
times between 2.75 and 6 h post-fertilization. Embryos
treated with SB-431542 at 3.7 h contain a small number
of trunk somites, but we detected no other mesodermal
tissues in the trunk (Fig. 4A1; Fig. 5). ntl was expressed in
a truncated axial domain and only a small number of dis-
organized trunk somites are apparent, as indicated by
MyoD expression (Fig. 4A4, A5). flh was expressed in two
bilateral domains within the ectoderm, but not at the
midline (Fig. 4A6), consistent with the lack of notochord
tissue in these embryos (Fig. 4A1, Fig. 5). The expression
of the pan-mesodermal marker, ntl, but not notochord
marker, flh, at the midline suggests that these cells are
specified to be dorsal mesoderm, but are unable to com-
plete the differentiation program [46,47]. The lack of
pax2.1 expression in the intermediate mesoderm indicates
that the pronephros was not specified at this time point
(Fig. 4A7). Therefore, only trunk somites were specified
following the shortest exposure time to Nodal signals.
Embryos treated with SB-431542 at later time points con-
tain a more diverse array of mesodermal tissues (Fig. 5).
Small amounts of notochord are detected in embryos
treated at 4 h (Fig. 4B1, arrow; Fig. 5). Red blood cells are
also apparent in live embryos examined at 48 h (Fig. 5).
flh  expressing cells populate the midline, but do not
induce expression of MyoD in adaxial cells within the seg-
mented mesoderm (Fig. 4B4-6). MyoD is still expressed in
adaxial cells in the presomitic mesoderm (Fig. 4B5).
pax2.1 expression is also apparent in embryos treated at 4
h (Fig. 4B7). The hatching gland and Kupffer's vesicle are
first visible in embryos treated with the drug at 4.3 h (Fig.
4C3, arrowhead; Fig. 5). Although we observed beating
hearts in embryos treated at 4.7 h, a functioning circula-
tory system was only established in embryos treated at 5 h
(Fig. 5). Since blood is specified before the heart, we
attribute the delay in circulation to the time required to
specify the cells comprising the vasculature, although we
have not directly examined these cell types. Tissues were
specified in the same temporal order in a time course
using SB-505124 (data not shown).
The total amount of mesoderm increases as embryos are
treated at successively later stages. Embryos treated at 3.7
h have between 5–7 trunk somites (Fig. 4A1, 5). By con-
trast, embryos treated at the onset of gastrulation contain
the normal complement of somites (Fig. 4E1, 5). Thus,
new somite tissue is induced throughout the blastula
SB-431542 rapidly blocks transcription of Nodal target genes Figure 2
SB-431542 rapidly blocks transcription of Nodal tar-
get genes. lefty1 expression in embryos treated with DMSO 
(A-C) or SB-431542 (D-F) at 4.3 h (dome stage), and fixed 
after 15 minutes (A, D), 30 minutes (B, E) or 45 minutes (D, 
F).BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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period. Similarly, a truncated notochord forms in
embryos treated at 4 h (Fig. 4B1, 6, arrow), but notochord
tissue extends more anteriorly when later stage embryos
are treated (Fig. 4C1-E1; C6-E6). We were unable to detect
a difference in the length of notochord in embryos treated
at 5 h and 6 h (Fig. 4D6, E6). Expression of flh in the neu-
rectoderm diminishes concomitantly with its expansion
along the midline, indicating that signals from the meso-
derm inhibit the differentiation of some neural tissues
(Fig. 4A6-C6). pax2.1 expression is weak when Nodal sig-
naling is blocked at 4 h (Fig. 4B7), but intensifies when
Nodal signaling is blocked at later stages (Fig. 4C7-E7).
This demonstrates that after 4 h, Nodal signals act to spec-
ify the somites, notochord and pronephros, simultane-
ously. This argues against, but does not completely
exclude, a model in which Nodal signals specify different
mesoderm and endodermal cell types during distinct
time-windows.
Nodal signals pattern the animal-vegetal axis in a time-
dependent manner
Somite progenitors extend to the most animal region of
the mesoderm territory in the pre-gastrula stage embryo,
while progenitors of the hatching gland are restricted to
the margin [5,6,17]. Thus, our data suggests a general
trend in which animal cell types are specified by shorter
periods of Nodal signaling than marginal cell types. To
test this, we asked when Nodal signals are required to
specify the neural plate, notochord, prechordal plate and
endoderm, which are marked by expression of cyp26, flh,
gsc  and  sox17, respectively (Fig. 6A1-C1, E1). Embryos
treated at MBT do not express flh, gsc or sox17 (Fig. 6B2,
C2, E2). cyp26 is expressed at the margin, consistent with
fate mapping studies showing that marginal cells adopt
neural cell fates in the absence of Nodal signaling (Fig.
6A2) [12]. This domain shifts toward the animal pole
with later treatments, reaching its normal location in
embryos treated at 5 h (Fig. 6A2-5). flh is first observed at
the margin in embryos treated at 3.7 h (Fig. 6B3), but
these cells do not differentiate into notochord (Fig. 4A6,
N = 20/21). flh is expressed at higher levels in embryos
treated at later stages and the cells do become notochord
(Fig. 6B2-6; Fig. 4B6-E6). gsc is not observed in embryos
treated at 3.7 h (N = 17), but we detect a small number of
gsc expressing cells in embryos treated at 4.3 h (Fig. 6C3,
C4; N = 9/22). gsc is expressed at normal levels in all
embryos treated at 5 h (Fig. 6C5; N = 20). This indicates
that Nodal signals are required between 4.3 h and 5 h to
Treatment at MBT blocks the response to receptors activated during the cleavage stages Figure 3
Treatment at MBT blocks the response to receptors activated during the cleavage stages. Embryos injected at 
the 1–4 cell stage with 10pg β-galactosidase (A-D), TARAM-D (E-H), or sqt (I-L) mRNA, and treated at 2.75 h with DMSO (A, E, 
I, C, G, K) or SB-431542 (B, F, J, D, H, L). (E, G) TARAM-D induces ectopic body axes and gsc expression. (F, H) The effects of 
TARAM-D are suppressed by treatment with SB-431542. (I, K) sqt overexpression arrests epiboly and induces ubiquitous 
expression of gsc. (J, L) The response to ubiquitous Sqt is blocked by treatment with SB-431542. Images of live embryos at 30 
h, anterior to the left (A, B, E, F, I, J). Animal pole views of fixed embryos at 5 h, dorsal to the right (C, D, G, H, K, L).BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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specify the prechordal plate. Kupffer's vesicles are also
specified at this time, as indicated by our analysis of live
embryos (Fig. 4C3; Fig. 5) and of sox17 expression in the
dorsal forerunner cells (Fig. 6E4, arrowhead; N = 17).
sox17 is expressed in endoderm progenitors in embryos
treated at 5 h (Fig. 6E5; N = 15). The paired-box transcrip-
tion factor mezzo acts upstream of sox17, and is expressed
along the same time course (Fig. 6D1-D5) [48]. On the
dorsal side of the embryo, therefore, specification of mar-
ginal cell types, but not more animal cell types, is inhib-
ited by late drug treatments.
We next asked if Nodal signals act similarly in the ventro-
lateral margin. The teleost heart is composed of two
Nodal signals pattern the mesoderm during a three-hour time window Figure 4
Nodal signals pattern the mesoderm during a three-hour time window. (A1-A8) Trunk somites form in embryos 
treated at 3.7 h (A1, 5), but flh is expressed in four ectodermal domains (A6). (B1-B8) Embryos treated at 4 h contain more 
somites (B5). flh is expressed at the midline and small amounts of notochord tissue are observed in live embryos (B1, arrow). 
pax2.1 expression is also observed (B7). At later time points, embryos have progressively more somites and more notochord 
(C1-E7). flh expression extends further up the midline and pax2.1 is expressed more strongly. Kupffer's vesicle forms in 
embryos treated 4.3 h (C3, arrowhead). shhb is not expressed in embryos treated before gastrulation (A8-E8). Images of live 
embryos at 24 h, anterior to the left (A1-E1; A2-E2) or 14hpf (A3-E3); dorsal views of fixed embryos at 10 h (A4-E4; A6-E6; 
A8-D8) or 14 h (A5-E5; A7-E7). Control embryos are depicted in Fig. 1J-S, which are from the same experiment.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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chambers, the atrium and ventricle, which express atrial
myosin heavy chain (amhc) and ventricular myosin heavy
chain (vmhc), respectively (Fig. 7B1, C1) [49]. Both cham-
bers express cardiac myosin light chain 2 (cmlc2) (Fig. 7A1).
Despite a large region of overlap, atrial myocardial precur-
sors can be found in more animal locations and ventricu-
lar myocardial precursors are located closer to the margin.
We found that cmlc2  and  amhc  expression are first
detected when Nodal signaling is blocked at 4 h (Fig. 7A2,
B2 arrows; N = 16/20 and N = 18/21, respectively). vmhc
expression is never observed at this time point, indicating
that specification of atrial myocardium precedes specifica-
tion of ventricular myocardium (Fig. 7C2; N = 0/19). vmhc
expression is first observed in embryos treated at 4.3 h
(Fig. 7C3, N = 24/27). The short delay between specifica-
tion of atrial myocardial precursors and ventricular myo-
cardium is consistent with the small number of atrial
progenitors located in animal cells where ventricle myo-
cardial is not found [7]. The bilateral expression of heart
myocardial genes in embryos treated at 4.3 h is consistent
with the lack of endoderm at this stage (Fig. 7A3-C3) [50].
Myocardial precursors fuse into a tube at the midline
when Nodal signals are blocked at 4.7 h, when we first
observe beating hearts in live embryos (Fig. 7A4-C4; Fig.
5). We conclude that within the presumptive mesoderm
and endoderm, marginal cell types require longer periods
of Nodal signaling than other cell types.
Nodal levels control when cell fates are specified
We have shown that Nodal signals specify different cell
types within the mesoderm and endoderm at different
times, although there is a period during which they spec-
ify multiple tissues simultaneously. This could be
explained if the responding cells have fixed time windows
Time-dependent specification of mesodermal tissues by Nodal signals Figure 5
Time-dependent specification of mesodermal tissues by Nodal signals. Embryos were treated with SB-431542 at dif-
ferent stages of development between the mid-blastula transition and the onset of gastrulation, and were examined morpho-
logically at 14, 24 and 48 h for visible trunk somites, notochord, blood, Kupffer's vesicle, hatching gland, a beating heart and a 
functional circulatory system. The steep curves for somites, hatching gland, Kupffer's vesicle, and beating hearts indicates that 
specification of these tissues occurs rapidly and in a stepwise fashion. Specification of notochord and blood occurs over a 
longer period. The number of embryos examined at each time point is indicated.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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Nodal signals pattern the dorsal mesoderm and endoderm along the animal-vegetal axis in a time-dependent manner Figure 6
Nodal signals pattern the dorsal mesoderm and endoderm along the animal-vegetal axis in a time-dependent 
manner. Dorsal cell fates were examined in embryos treated with DMSO (A1-E1), or with SB-431542 at various time points. 
(A2-5) cyp26 expression was expressed at the margin in embryos treated at MBT, but is expressed in more animal locations at 
later time points. (B2-5) flh is first detected in embryos treated at 3.7 h. (C2-5) gsc is first observed in embryos treated at 4.3 h 
(dome stage), but is expressed at normal levels in embryos treated after 5 h (40% epiboly). mezzo transcripts are observed in 
embryos treated after 5 h (40% epiboly) (D5), but not at earlier stages (D2-4). sox17 is expressed in the dorsal forerunner cells 
in embryos treated 4.3 h (dome stage) (E4, arrowhead), but is first detected in endoderm progenitors in embryos treated at 5 
h (40% epiboly) (E5). Lateral views of embryos at 10 h are depicted in A1-5, dorsal to the right. Dorsal views of embryos at 7 
h (60% epiboly) (B1-C5), 5.5 h (germ ring) (D1-5) and 8 h (80% epiboly) (E1-5) are depicted. Arrowheads (E1, 4, 5) indicate 
sox17 in dorsal forerunner cells. All embryos are siblings.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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during which they need to be exposed to Nodal signals in
order to adopt particular fates. If so, then mesoderm and
endodermal cell fates will be specified at the same time as
wild type even when the Nodal dose is reduced. To test
this, we asked when cell fates are specified in sqt mutants,
which have reduced levels of Nodal signaling. We found
that flh expression at the midline was only observed when
Nodal signaling was blocked at 5 h in sqt mutants (Fig.
8A5; N = 15), as opposed to 4 hr in wild type (Fig. 4B6).
Thus, notochord specification is delayed by an hour in sqt
mutants. Specification of the prechordal plate and endo-
derm are also delayed in sqt mutants. gsc expression is
only apparent in sqt mutants treated at the onset of gastru-
lation (6 h) (Fig. 8B6, N = 21; compare with Fig. 6C4),
and sox17 expression is first apparent in embryos treated
at 7 h (Fig. 8C7, N = 16/20; compare with Fig. 6E5). We
also observed a delay in specification of ventrolateral cell
types in sqt mutants, since cmlc2 expression is only appar-
ent in embryos treated at 4.7 h (Fig. 8D4, arrowhead, N =
12/16; compare with Fig. 7A2). These results rule out the
possibility that presumptive mesoderm and endodermal
cells have discrete windows of competence that determine
their response to Nodal signals.
The delay in cell fate specification in sqt mutants suggests
that Nodal levels control when cells fates are specified. If
so, then specification of mesodermal and endodermal cell
types should be accelerated when Nodal levels are
increased. To test this, we examined flh,  gsc  and  sox17
expression in embryos injected with sqt mRNA and treated
with SB-431542 at different time points after MBT. flh
expression was not detected in control embryos (Fig.
9A1), but gsc and sox17 were both expressed ubiquitously
(Fig. 9B1, C1). Expression of all three genes was inhibited
when we blocked Nodal receptor activity at MBT (Fig.
9A2-C2). flh was broadly expressed in embryos treated at
Nodal signals pattern the ventrolateral mesoderm along the animal-vegetal axis in a time-dependent manner Figure 7
Nodal signals pattern the ventrolateral mesoderm along the animal-vegetal axis in a time-dependent manner. 
Heart myocardial cell fates were examined in embryos treated with DMSO (A1-C1), or with SB-431542 at various time points 
(A2-C5). (A2-C2) Embryos treated at 4 h, express small amounts of amhc and cmlc2, but not vmhc (arrows). (A3-3) cmlc2, 
amhc and vmhc are bilaterally expressed in embryos treated at 4.3 h. (A4-C5) All heart markers are expressed at the midline in 
embryos treated at 4.7 h. Images are dorsal views at 24 h, anterior to the left.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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3.7 h (N = 14), but gaps are often apparent at the animal
pole. This indicates that the notochord is specified earlier
in embryos with elevated Nodal signals than in wild type
(Fig. 9A3, compare with Fig. 4B6). Similarly, specification
of both prechordal plate and endoderm occur earlier in
embryos with elevated Sqt. gsc is first detected in embryos
treated at 3.7 h, as opposed to 4.3 h in wild type (Fig. 9B3,
N = 10/19; compare with Fig. 6C4), and is ubiquitously
expressed in all embryos treated at 4.3 h (Fig. 9B4; N =
12). This indicates that specification of prechordal plate is
greatly accelerated when Nodal signaling is elevated. sox17
is first observed in embryos treated at 4.3 h instead of 5 h
in wild type, representing a slight acceleration in endo-
derm specification as compared to wild type (Fig. 9C4, N
= 10/12; Fig. 6E5). These results show that the level of
Nodal signaling determines when mesoderm and endo-
dermal cell fates are specified.
According to the "ratchet-model", cells generate a
response appropriate to the highest dose to which they are
exposed independently of the duration of exposure [33].
If true, then cells should always adopt the most marginal
fate when they are exposed to a uniformly high Nodal
dose, regardless of how long the exposure lasts. In contrast
Cell fate specification is delayed squint mutants Figure 8
Cell fate specification is delayed squint mutants. Cell fates were examined in sqt mutant embryos treated with DMSO 
(A1-D1), or with SB-431542 at various time points. (A1-7) flh was first expressed at the midline in embryos treated at 5 h (A5). 
(B2-7) gsc expression is first detected in embryos treated at 6 h (B6). (C2-7) sox17 expression is first detected when embryos 
are treated at 7 h (C7). (D1-7) cmlc2 expression was first detected in embryos treated 4.7 h (D4, arrowhead). Dorsal views of 
10 h (A1-B7), 8 h (C1-C7) or 24 h (D1-D6). In D1-D6, anterior is up. The embryos in Figs. 8 and 9 are from the same clutch 
and weretreated in parallel, along with wild type controls (not shown).BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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to this prediction, however, we found that cells in Sqt-
injected embryos are transiently specified to the more ani-
mal flh expressing fate (Fig. 9A4). As the duration of expo-
sure increases, flh expression gradually diminishes (Fig.
9A4-A7), and gsc and sox17 expression increase concomi-
tantly (Fig. 9B4-C7). This demonstrates that cells adopt
progressively more marginal identities in response to
increasing exposure times to Nodal signals. These results
rule out the possibility that presumptive mesoderm and
endodermal cells respond to Nodal signals by a ratchet-
ing-type mechanism.
Discussion
Chemical inhibitors of ALK 4/5/7 are new tools for 
dissecting the roles of Nodal signals
In this study, we addressed the question of when mem-
bers of the Nodal-related subclass of the TGF-β super-
family act to pattern the mesoderm and endoderm. We
took a pharmacological approach to inactivate Nodal sig-
naling at different times, and examined the resulting cell
fates by an extensive analysis of gene expression and mor-
phology. Three lines of evidence show that we were able
to inhibit zygotically expressed Nodal signals. Firstly, we
generated a phenocopy of sqt; cyc double mutants by treat-
ing embryos with 800 μM SB-431542 at the mid-blastula
stage, when zygotic expression of sqt and cyc initiates (Fig.
1). Secondly, we could phenocopy cyc single mutants by
treating embryos at the onset of gastrulation, when cyc
expression predominates (Fig. 4). These two experiments
demonstrate that our treatment reduces receptor activity
to at least the levels in the respective mutants. We con-
firmed our results with a second drug, SB-505124, which
is more potent and soluble than SB-431542 (Fig. 1; data
not shown), which rules out possible artefacts due to the
high dose of SB-431542. Finally, drug treatment in the
late blastula stages inhibited expression of a Nodal target
gene within 30 minutes (Fig. 2).
Our results differ markedly from those of earlier studies,
in which 50 μM SB-431542 was unable to reproduce the
sqt; cyc phenotype when added to embryos older than the
8-cell stage [40,41]. Two technical aspects of our treat-
ment protocol may account for our different results. First,
we used a much higher dose of SB-431542 (800 μM) than
the other groups. Secondly, we perforated the embryos to
ensure the drug fully penetrated the embryos. Perforation
was not necessary with SB-505124, which was also effec-
tive at a much lower dose (50 μM). We conclude that the
Cell fate specification is accelerated when Nodal levels are increased Figure 9
Cell fate specification is accelerated when Nodal levels are increased. Embryos were injected with sqt mRNA at the 
1–4 cell stage and treated with DMSO (A1-C1) or SB-431542 at various time points (A2-C7). Sqt induces ubiquitous expres-
sion of gsc and sox17 (B1, C1) but not flh (A1). (A2-C2) SB-431542 treatment at MBT blocks expression of each of these mark-
ers. flh is strongly expressed in embryos treated at 3.7 h (A3), but fades at later time points (A4-7). gsc expression is first 
detected in embryos treated at 3.7 h (B3), and expands at later time points (B4-7). sox17 expressing cells are first detected 
when embryos are treated at 4.3 h (C4), and expands at later time points (C5-7). Animal pole views at 10 h.BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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milder effects of the drug reported by others are due to the
poor ability of SB-431542 to penetrate the embryo as the
number of cells increases during the cleavage stages. Even
though multiple ligands can activate the ALK4/5 and 7
receptors, our phenotypes all resemble those resulting
from reductions of nodal-related  gene function [17,23].
This indicates that the other Activin-like ligands are either
not expressed during the stages we examined or act down-
stream of Nodal signals.
Time-dependent patterning of the animal-vegetal axis by 
Nodal signals
Previous attempts to determine when Nodal signals spec-
ify different mesoderm and endoderm cell types have
focused on the analysis of oep mutant embryos. In Zoep
mutants, late Nodal signaling is blocked due to the
absence of an essential co-receptor, and prechordal plate
and endoderm do not form [32,51]. It is not clear, how-
ever, whether these defects are due to the absence of late
Nodal-signaling activity, or to the reduction of signaling
levels caused by the decay of maternally supplied Oep
protein. In an alternate approach to determine the role of
Nodal signals at different times, oep function was restored
to MZoep mutants at different stages, rescuing the ability
of mutant cells to respond to Nodal signals [31,52]. In
these experiments, restoring Nodal signaling at early
stages completely rescued MZoep  mutants. By contrast,
prechordal plate and endoderm was missing when Nodal
signaling was restored at later stages. Although these
results are apparently consistent with our findings, we
found that sqt and cyc expression are expressed at very low
levels when oep function is supplied at late stages (4 h;
Hagos and Dougan, submitted). Since the defects in late-
rescued MZoep mutants result from aberrant nodal-related
gene expression, these experiments do not address the
question of when Nodal signals are required to specify cell
fates.
By conditionally inactivating the Nodal receptors, we were
able to determine the specification state of the presump-
tive mesoderm and endoderm at different embryonic
stages. We found a time-dependent progression of cell fate
specification along the animal-vegetal axis, consistent
with earlier studies demonstrating that Nodal signals pat-
tern the animal-vegetal axis, but not the dorsoventral axis
[17]. Blocking Nodal signals at late stages inhibits forma-
tion of tissues derived from the margin, such as pre-
chordal plate and endoderm, but not from more animal
regions, such as notochord or somites (Figs. 4, 5, 6). Pre-
vious studies have determined that endoderm and pre-
chordal plate require higher doses of Nodal signals than
somites [17,31]. This suggests a linkage between Nodal
dosage and the length of exposure.
Nodal levels control when cells are specified to become 
mesoderm and endoderm
Our results place Nodal signals at the top of a develop-
mental program that determines the fates of responding
cells and controls when these fates are specified. We con-
sidered the possibility that Nodal signals pattern the mes-
oderm and endoderm by acting in fixed time windows to
specify different cell types. When Nodal levels are low, as
in sqt mutants, specification of endoderm does not begin
until early gastrulation (7 h; Fig. 8C7). By contrast, when
Nodal levels are high, specification of endoderm begins
1.7 h earlier (Fig. 9C4). We conclude that cell identities
are specified at different times depending on the Nodal
dosage (Figs. 8, 9). These results exclude the possibility
that cells have fixed time windows during which they can
adopt particular mesoderm and endodermal fates in
response to Nodal signals. To the contrary, the level of
Nodal signalling determines when cells are specified to
adopt particular mesoderm and endodermal identities.
Previous cell transplant experiments defined a broad win-
dow of competence during which cells can respond to
mesoderm and endoderm inducing signals, which we
now know to be the Nodal-related proteins [53,54].
Experiments in Xenopus animal caps demonstrated that
this window of competence is controlled by an intrinsic
timing mechanism and ends by mid-gastrulation [55].
Our results show that within this broad window, cells
have a considerable degree of flexibility as to when they
can become mesoderm and endoderm that depends on
the levels of Nodal signals. At the molecular level, the loss
of the ability to respond to Nodal signals could reflect the
Nodal-dependent induction of a feedback inhibitor of the
pathway. Consistent with this idea, expression of the
secreted Nodal antagonist Lefty is under the control of
Nodal signaling [23,56]. Thus, one role of Lefty could be
to place a temporal limit on when cells can respond to
Nodal signals. In support of this, Nodal signals persist
well into gastrulation when lefty function is depleted, and
act during this time to convert ectoderm into mesoderm
and endoderm (X. Fan and S. Dougan, unpublished data)
[26,57].
The length of exposure to Nodal signals determines cell 
fate choices
Cells are exquisitely sensitive to the dose of Activin-like
signals. Experiments with dissociated Xenopus animal cap
cells showed that as few as 100 molecules of Activin
induce expression of the pan-mesodermal marker, Xbra,
whereas 300 bound molecules induce gsc expression [35].
In these experiments, cells were exposed to different doses
of Activin for 10 minutes and changes in cell fate were
assessed hours later. The results supported the view that
cells "ratchet-up" their response as a morphogen gradient
is established and the dose of Activin crosses particularBMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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threshold levels (Fig. 10A)[33]. Because the length of
exposure was constant, these experiments did not address
the effects of prolonged exposure to Activin on cell fate
decisions. In our experiments, by contrast, we examined
the response to the endogenous mesoderm and endo-
derm inducing signals in whole zebrafish embryos. Mar-
ginal cells were continuously exposed to Nodal signals
until we blocked the response by drug treatment. Our
results emphasize the importance of the length of expo-
sure in determining the overall dose and consequent fate
choice. Importantly, all mesoderm and endodermal cell
types are present in sqt mutants, but are specified at later
times than in wild type. The only Nodal-related protein in
these embryos is Cyc, which has a shorter range than Sqt
and is expressed at reduced levels in sqt mutants [17,25].
Thus, prolonged exposure to low doses of a signal com-
pensates for the overall reduction of levels. Furthermore,
the long-range action of a secreted factor is not essential
for normal development of the two germ layers in
zebrafish.
Generating a response to a cumulative Nodal dose
We found that cells respond to the cumulative dose of
Nodal signals to which they are exposed. In embryos
exposed to a uniform, high Nodal dose, cells exhibit a
time dependent transformation towards more marginal
fates as the length of exposure increases (Fig. 9). This
means that cells must have a mechanism to record the
duration of their exposure to Nodal signaling and to gen-
erate a response to the cumulative dose. Although this reg-
ulation may occur at many different levels, the ultimate
readout is at the level of gene transcription. Of the marker
genes we analyzed, gsc is a likely direct target of the Nodal
pathway [58]. gsc expression initiates at 4 h in the absence
of both sqt and cyc function, but quickly decreases [17].
This indicates that Nodal signals are required for mainte-
nance, but not for the induction of gsc expression. In this
study, we showed that gsc expression is lost when Nodal
signaling is inactivated at 4.3 h, but continues when
Nodal signaling is blocked at 5 h (Fig. 6). Thus, Nodal
input is required for about an hour in order to maintain
gsc expression. After this transient maintenance phase, gsc
expression continues independently of Nodal, by an
unknown mechanism. In sqt mutants, it takes a longer
period of time for the gsc promoter to transit to the Nodal
independent phase, whereas the gsc promoter reaches this
state more rapidly when Sqt is overexpressed. Other genes
have been shown to undergo similar phases of gene regu-
lation, most notably the Drosophila engrailed gene [59],
but this is the first case to our knowledge in which the lev-
els of a secreted factor control the length of the mainte-
nance phase of a target gene.
A spatio-temporal gradient model for patterning by Nodal 
signals
Any model for how Nodal signals act to pattern the mes-
oderm and endoderm must account for four observations.
First, the model must explain how adjacent cells become
exposed to different levels of Nodal signals. Fate mapping
studies show that precursors of cell types that require dif-
ferent levels of Nodal signaling, such as somites and endo-
derm, are juxtaposed in the pre-gastrula stage embryo
[5,17]. Second, the model must account for our observa-
tion that the blastomeres are highly dynamic during the
period they respond to Nodal signals. We found that
Nodal signals act primarily before 5 h (40% epiboly)
(Figs. 4, 5, 6), a period in which cells divide rapidly and
frequently change positions with respect to each other
[60]. This presents a particular challenge to classic morph-
ogen gradient models, which generally assume a static
field of responding cells. Third, the model must explain
how a short-range signal, like Cyc, can specify the same
cell types as a long-range signal, like Sqt. Finally, the
model must account for our observation that cells
respond to the cumulative dose of Nodal signals.
We propose that the total Nodal dose is a function of both
the length of time a cell is exposed to Nodal signals and
the distance of a cell from the Nodal source (Fig. 10B).
Key predictions of this model remain to be tested, but it
accounts for all these observations. In this view, cells that
remain near the Nodal source for an extended period
would receive a high dose and adopt a marginal cell fate,
such as prechordal plate or definitive endoderm. Con-
versely, cells that move away from the source after a short
time would receive a lower dose and become somites.
Specification of mesoderm and endoderm is delayed in sqt
mutants because it takes longer than in wild type for cells
to accumulate the necessary Nodal dosage. Because the
gradient of positional information is influenced by the
length of time responding cells are exposed to the signal-
ing source and their distance from the source, we call this
the spatio-temporal gradient model. In other species,
Nodal signals also pattern tissues comprised of dynamic
cell populations, such as the node and primitive streak in
mice and Hensen's node in the chicken [61,62]. Thus, cell
movements could provide a general mechanism for gen-
erating a gradient of exposure to Nodal signals during
mesoderm patterning in all vertebrates.
Our model predicts that a stable source of Nodal signals
exists in the embryo that is independent of the dynamic
cell movements of the responding cell population. We
propose that the extraembryonic yolk syncytial layer
(YSL) acts as this source. Sqt is normally expressed in this
tissue and can induce fate changes in overlying blast-
omeres when overexpressed in the YSL [19,24]. We sug-
gest that Nodal signals in the YSL act to induce and/orBMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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maintain nodal-related  gene expression in the overlying
blastomeres via the autoregulatory pathway. If a cell that
is initially close to the YSL moves away, it will lose expres-
sion of sqt and cyc. Conversely, sqt and cyc expression will
be induced in a cell as it moves closer to the YSL. Thus, the
autoregulatory pathway provides a mechanism by which
a stable zone of Nodal signaling can be imposed upon the
dynamic, intermixing population of cells at the embryo
margin.
Conclusion
Our data indicate that Nodal signals act in a time-depend-
ent manner to pattern the mesoderm and endoderm.
Three lines of evidence support the idea that cells respond
Models for forming a gradient of Nodal signals over time Figure 10
Models for forming a gradient of Nodal signals over time. In the ratchet model (A), the morphogen spreads through a 
tissue over time and cells receive different Nodal doses at different times. Cells respond to the highest dose to which they are 
exposed. In the spatio-temporal gradient model (B), cells freely move into (not depicted) and out of (arrows) a zone of signal-
ing activity (red rectangle). A short residence time in this zone determines a low cumulative dose of Nodal signals (green cir-
cle), whereas longer residence times determine higher cumulative Nodal dose (yellow and blue circles).BMC Developmental Biology 2007, 7:22 http://www.biomedcentral.com/1471-213X/7/22
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to the cumulative dose of Nodal signals. First, marginal
cell types, which are specified by the highest Nodal dose,
require the longest exposure to Nodal signals. Second, cell
fate specification is delayed when Nodal levels are
reduced, and accelerated when Nodal levels are increased.
Finally, in response to a uniform, high Nodal dose, cell
fates transform toward progressively more marginal iden-
tities as the length of exposure increases. These results rule
out the possibility that Nodal signals act during discrete
time windows to specify different mesodermal and endo-
dermal cell types. They are also inconsistent with the
"ratcheting-up" model, in which the absolute number of
occupied receptors determines cell fates, not the duration
of exposure. We conclude that cells respond to the cumu-
lative Nodal dose, which we suggest is a product of the
distance of the responding cell from the signaling center
and the length of exposure.
Methods
Zebrafish strains and staging
We used the WIK strain to obtain wild type embryos.
Embryos homozygous for the sqtcz35  null allele were
obtained from crossing mutant adults. oeptz57  mutant
adults were obtained by mRNA injection, as previously
described [10]. In all experiments, the embryonic stages
were determined by morphology and are reported as
hours postfertilization (h) at 28.5°C, according to Kim-
mel et al. (1995).
Drug treatment
SB-431542 (4- [4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl-
1H-imidazol-2- yl]benzamide), was obtained from Tocris
(Ellisville, MO) and stored as a 100mM stock in DMSO at
-20°C. SB-505124 (2-(5-benzo[1,3]dioxol-5-yl-2-tert-
butyl-3Himidazol- 4-yl)-6-methylpyridine hydrochlo-
ride) was a kind gift from GlaxoSmithKline (King of Prus-
sia, PA) and is stored at 10 mM in DMSO at 4°C. For the
drug time course studies shown in Figs. 1 and 4, approxi-
mately 1000 embryos equivalently staged embryos from
3–4 single pair matings were pooled, split into 10 dishes
at a density of 100 embryos/dish, and raised in an incuba-
tor at 28.5°C. For drug treatment, embryos from one dish
were removed at the desired stage, perforated near the
margin with a pulled capillary tube, and split into glass
dishes containing the drug in 5 ml embryo medium, at a
density of 25 embryos/dish. Embryos were fixed at 10h
and split into three groups for analysis of ntl, flh or shhb
expression, or fixed at 14h and split into two groups for
analysis of MyoD or pax2.1. Time courses depicted in other
figures followed the same protocol, but embryos were
fixed at the stages indicated for analysis of marker gene
expression. In each figure, representative images are
shown, and all embryos were treated on the same day.
Embryos damaged by the perforation were discarded.
Embryos treated with SB-505124 did not require perfora-
tion. In all experiments, some embryos in each experi-
ment were allowed to develop until 24 h and examined
morphologically to verify the efficacy of the treatment. All
experiments were performed at least two times. The effec-
tive dose on 2.75 h embryos SB-431542 was determined
in a titration of 5 μM-1mM SB-431542 or 3 μM–75 μM
SB-505124. SB-431542 treatment was always associated
with the formation of a dark precipitate in the solution. At
800 μM, all embryos resembled sqt; cyc mutants, whereas
lower doses generated milder phenotypes similar to Zoep
mutants [51]. This milder phenotype is also observed by
treating cleavage stage embryos with 50 μM SB-431542
(data not shown) [40,41]. The previously described toxic
effects of SB-431542 in cell culture are apparent at doses
above 800 μM on blastula stage embryos and above 100
μM on cleavage stage embryos (data not shown) [38]. For
SB-505124, the lowest dose that produced the sqt; cyc phe-
notype ranged from 30–50 μM, depending on the age of
the drug.
Microinjections and whole-mount in situ hybridization
The sOep, sqt and TARAM-D cDNAs were described previ-
ously [19,32,45]. Sense transcripts were synthesized using
the Message Machine kit (Ambion, Inc., Austin TX). We
injected 10pg sqt, TARAM-D or β-galactosidase mRNA into
chorionated embryos at the 1–4 cell stage. 100pg sOep
mRNA was co-injected into the YSL of MZoep mutants
with the Oregon Green 488 lineage tracer dye (Invitrogen,
Inc., Carlsbad, CA) to verify the targeting of the injection,
as described [31]. In situ hybridizations were performed as
in Dougan, et al., 2003. We used the following probes: sqt,
cyc, gsc, ntl, flh, MyoD, pax2.1, shhb, sox17, mezzo, cyp26,
cmlc2, amhc and vmhc [16,19,23,46-49,63-69].
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